Wegovy weight loss progress: what 'slow and steady' actually means

What did @luckiesknickers actually say?

Broadly, this creator is saying Wegovy is working, but slowly, and that consistent exercise is helping them make the most of an expensive medication. They're not checking the scale obsessively, they're going by how clothes fit, and they completed seven workout sessions last week. Nothing dramatic here, just a progress update from someone being relatively measured about their expectations.

The specific claims worth examining: that Wegovy produces gradual, noticeable results; that avoiding daily weigh-ins reduces psychological stress; that high exercise frequency is the right way to "make the most" of GLP-1 treatment; and that cost is a real barrier. These are all worth unpacking, because some are well-supported and at least one deserves a closer look.

Does the science back this up?

Mostly, yes. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed mean weight loss of around 14.9% body weight over 68 weeks on semaglutide 2.4mg, which is the dose in Wegovy. That's an average, spread over more than a year. Early results are often modest, which matches what this creator is describing.

On avoiding the scale: there's legitimate clinical support here. Mensinger et al. (2016, Health Psychology) found that frequent self-weighing in people with a history of weight-related stress can increase anxiety and disordered eating behaviors without improving outcomes. Using clothing fit as a proxy isn't scientifically rigorous, but it's not irrational either, especially if scale anxiety has previously derailed adherence.

On exercise: the SURMOUNT and STEP trials didn't mandate exercise, but the combination of GLP-1 therapy with resistance training specifically has emerging support. Lundgren et al. (2023, Obesity) found that pairing semaglutide with structured resistance exercise helped preserve lean muscle mass, which matters because GLP-1 drugs can cause loss of fat-free mass alongside fat.

What did they get wrong (or right)?

The creator doesn't make many hard factual claims, so there's not much to debunk here. What they get right is the framing: slow progress is normal and expected, not a sign the medication isn't working. They also correctly identify cost as a real issue. Wegovy's list price in the UK and US is significant, and real-world access remains uneven.

Where things get slightly murkier is the "seven sessions last week" detail. That's a high volume, particularly if someone is in a caloric deficit from appetite suppression. Overtraining while undereating is a genuine risk on GLP-1 medications. The creator doesn't mention what kind of exercise, and if it's mostly cardio at high frequency without adequate protein intake, they may be accelerating muscle loss rather than preventing it. That's not a catastrophic claim, but it's worth flagging. They don't get this wrong explicitly, but they're missing a key piece of context.

Credit where it's due: they're not promising a timeline, not claiming dramatic transformation, and not recommending dosing. That's better than most GLP-1 content on TikTok.

What should you actually know?

If you're on Wegovy or semaglutide and progress feels slow, the trial data suggests that's normal and does not mean the drug isn't working. The STEP 1 trial showed meaningful weight loss continuing through week 68, with much of it occurring after the first 16 weeks. Expecting rapid results early is a setup for premature discontinuation.

Exercise is genuinely beneficial alongside GLP-1 therapy, but the type matters. Resistance training appears more protective of lean mass than high-volume cardio alone, based on current evidence. Seven sessions per week is not inherently wrong, but recovery and protein intake need to match that load, especially when appetite is suppressed by the medication.

Using clothing fit as a progress metric has practical merit for people with scale-related anxiety, but it's imprecise. Body composition can shift significantly, including muscle loss, without visible changes in clothing fit. Periodic body composition assessment, even informally, gives a more complete picture. A registered dietitian familiar with GLP-1 protocols can help structure exercise and nutrition to support the medication's effects rather than inadvertently work against them.